J&J COVID-19 vaccine in limbo as U.S. panel delays vote on resuming shots
Posted on AllSides April 14th, 2021
From The Center
Johnson & Johnson’s COVID-19 vaccine remained in limbo on Wednesday as a U.S. health panel called for more data before making a decision on how and whether to resume use of the one-dose shot, putting off a vote for a week or more.
